SCHEMBL3223975

SCHEMBL3223975

O=C(C=Cc1ccc(O)c(Cl)c1)CC(=O)C=Cc1ccc(O)c(Cl)c1

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 7/20 0.88
APP P05067 4/20 0.59
AKR1B1 P15121 3/20 0.59
MAOB P27338 3/20 0.59
MAPT P10636 3/20 0.59
CYP2D6 P10635 2/20 0.59
CYP2C9 P11712 2/20 0.59
TSHR P16473 2/20 0.59
HSD17B10 Q99714 2/20 0.59
TOP2A P11388 2/20 0.59
HDAC2 Q92769 2/20 0.59
PTGS2 P35354 2/20 0.59
GLO1 Q04760 2/20 0.59
CAMK2A Q9UQM7 2/20 0.59
HDAC8 Q9BY41 2/20 0.59
ABCB1 P08183 2/20 0.59
MAOA P21397 2/20 0.59
CYP2C19 P33261 1/20 0.59
KDM4E B2RXH2 1/20 0.59
MEN1 O00255 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3223964 1.00 BACE1 (0.88) BACE1APPAKR1B1MAOBMAPT
SCHEMBL3221692 0.94 BACE1 (1.00) BACE1AKR1B1MAOBCYP2D6CYP2C9
SCHEMBL3221705 0.94 BACE1 (1.00) BACE1AKR1B1MAOBCYP2D6CYP2C9
SCHEMBL9800788 0.92 BACE1 (0.76) BACE1APPAKR1B1MAOBMAPT
SCHEMBL27211513 0.88 IAPP (0.73) BACE1APPAKR1B1MAOBMAPT
SCHEMBL3209412 0.87 APP (0.84) BACE1APPAKR1B1MAOBMAPT
SCHEMBL3209426 0.87 APP (0.84) BACE1APPAKR1B1MAOBMAPT
SCHEMBL3221740 0.86 MAPT (0.78) BACE1APPAKR1B1MAOBMAPT
SCHEMBL3221754 0.86 MAPT (0.78) BACE1APPAKR1B1MAOBMAPT
SCHEMBL6022866 0.84 KDM4E (0.70) BACE1APPAKR1B1MAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 BACE1 1/4885APP 2/4885AKR1B1 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.